Precision Medicine Software Market is estimated to expand at a healthy CAGR of ~10% by 2026

BRUSSELS - Sept. 20, 2022 - PRLog -- Precision medicine software (platforms, data-sharing networks, clinical decision support software, AI-enabled, etc.) provides the healthcare/life sciences community with integrated data and data-driven insights to strengthen their precision medicine program.

The global precision medicine software market is anticipated to witness a CAGR of ~10%, driven by the growing research in the field of genomics/precision medicine, significant VC funding, increasing government support, and rapid shift towards personalized treatments.

The Change from the Leading One-Size-Fits-All Approach to Personalized Care
The precision medicine approach promises better clinical outcomes, safer medicines, and less wastage/cost savings. With the growing demand to deliver value to healthcare systems, drug developers have begun to move away from the traditional one-size-fits-all approach to the personalized care approach.

In 2020, the FDA approved 20 personalized medicines and biologics (39% of the new approvals). Over the past five years, precision medicines have accounted for a quarter or more of all new drugs approved by the FDA each year. With the rising interest and growing opportunities in precision medicine, the demand for precision medicine software is also anticipated to grow.

Favorable Government Initiatives
Recognizing the long-term benefits of personalized care in improving population health and reducing healthcare costs, governments around the world are supporting advanced treatments such as precision medicine through initiatives, regulatory changes, and/or funding research.

For instance,

• In the US, The Oncology Care Model, a specialty payment and delivery model developed by the CMS Innovation Center is providing incentives that have led to a surge of large community provider networks implementing precision medicine initiatives.
• Some of the other programs to advance the research/use of precision medicine include The Precision Medicine Initiative (PMI), All of Us Research Program, precisionFDA, and Million Veteran Program.
• In addition, FDA issued seven guidance documents on precision medicine in 2020. All of these efforts would ultimately drive demand for precision medicine software market.

Explore Premium Report on Precision Medicine Software Market @ https://meditechinsights.com/precision-medicine-software-market/

Competitive Landscape Analysis of Precision Medicine Software Market
The global precision medicine software market is highly competitive and fragmented. Some of the key/promising players in this market include Syapse, Fabric Genomics, Sophia Genetics, 2bprecise, PierianDx, Inc., PhenoTips, Foundation Medicine, Inc., GenomOncology, LLC, Translational Software, Inc., LifeOmic Health, LLC, Sunquest Information Systems, Inc., Tempus, Human Longevity, Inc., and N-of-One Inc.